Company intelligence / Profile preview

Ophtec

Groningen, Groningen, Netherlandsophtec.com ↗

Ownership: Private
Employees: ~150
Development stage: Commercial

Overview

Ophtec has a 40-year track record in developing and commercializing intraocular lenses (IOLs) for cataract and refractive surgery. Its portfolio includes monofocal, toric, presbyopia-correcting IOLs and phakic IOLs. Recent clinical trials include the ArtiPlus Phakic IOL for presbyopia correction. The company’s Artiplus lens with Continuous Transitional Focus technology has shown promising results in early clinical use.

Therapeutic areas: Ophthalmology
Modalities: Device
Industry: Implantable Medical Devices

Partnerships

Not explicitly listed; works closely with ophthalmologists globally.

Beyond the preview

Go deeper on Ophtec.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ophtec.

Explore the full profile